 |
 |
 |
 |
 |
 |
Sains Malaysiana 47(11)(2018): 2777–2782 http://dx.doi.org/10.17576/jsm-2018-4711-20
Intratympanic Methylprednisolone
Injection in Idiopathic Sudden Sensorineural Hearing Loss after
Failure of Systemic Corticosteroid Therapy (Suntikan Metilprednisolon Intratimpanum
dalam Idiopati Kurang Pendengaran Sensorineuron Mengejut selepas
Kegagalan Terapi Kortikosteroid Sistemik) HO HON
LIAN1,3,
RUSZYMAH
BINTI IDRUS2, LOKMAN BIN SAIM1
& AMINUDDIN BIN SAIM1,3* 1KPJ Healthcare University College,
Lot PT 17010, Persiaran Seriemas, Kota Seriemas, 71800 Nilai,
Negeri Sembilan Darul Khusus, Malaysia 2Department of Physiology, UKM Medical
Faculty, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, 56000 Kuala
Lumpur, Federal Territory, Malaysia 3Department of Otorhinolaryngology
Head and Neck Surgery, KPJ Ampang Puteri Specialist Hospital,
Jalan Mamanda 9, Taman Ahmad Razali, Ampang Jaya, 68000 Ampang,
Selangor Darul Ehsan, Malaysia Diserahkan: 28 Mac 2018/Diterima:
30 Julai 2018 ABSTRACT Idiopathic sudden sensorineural
hearing loss (ISSNHL) is considered to be an otological emergency. The
intratympanic (IT) steroid injection technique is introduced
to decrease the side effects of systemic steroids and assumed
to deliver a higher concentration of corticosteroids into the
affected cochlea. The objective of the current study was to evaluate
the hearing outcomes of high dose IT methylprednisolone among ISSNHL patients
after failure of systemic corticosteroid therapy (SCT).
Hearing outcomes of SCT were evaluated over a 15 months period.
Upon failure of SCT, the treatment was continued with
higher dose IT steroid (methylprednisolone 62.5 mg/mL). Pre-treatment
and post-treatment audiometric evaluations were analysed using
pure tone audiogram (PTA). There were 36 patients diagnosed with ISSNHL
included in the study. After two weeks of SCT,
eighteen (56.3%) patients had hearing improvement of more than
10 dB. Another fourteen (43.7%) patients had no hearing improvement
(less than 10 dB). Following that, twelve patients were recruited
for weekly IT methylprednisolone
for three weeks. During the one month follow up after completion
of IT
therapy, six patients (50%) showed more than 10
dB improvement in the PTA with
a mean of 19.37 dB (p<0.05). Out of the six, two patients had more than 20 dB hearing
improvement. Almost all patients in this study had an improvement
in their symptoms of tinnitus and vertigo. High dose IT methylprednisolone
after failure of SCT resulted in significant improvement
in the patients’ hearing outcome during one month follow up. The
IT
therapy not only improved the patients’ hearing
but in addition reduced the symptoms of tinnitus and vertigo.
Keywords: Intratympanic; methylprednisolone;
sudden hearing loss ABSTRAK Kehilangan pendengaran sensorineuron
mengejut idiopati (ISSNHL) dianggap sebagai kecemasan
otologi. Teknik suntikan steroid intratimpanum (IT)
diperkenalkan untuk mengurangkan kesan sampingan steroid sistemik
dan diandaikan memberi tumpuan yang lebih tinggi daripada kortikosteroid
ke koklea yang terjejas. Objektif kajian adalah untuk menilai
hasil pendengaran dos yang tinggi metilprednisolon IT dalam kalangan pesakit ISSNHL
selepas kegagalan terapi sistemik kortikosteroid
(SCT).
Laporan hasil SCT telah dinilai dalam tempoh 15 bulan. Atas kegagalan
SCT,
rawatan diteruskan dengan dos IT steroid yang tinggi (metilprednisolon
62.5 mg/mL). Penilaian pra dan pasca rawatan audiometrik dianalisis
menggunakan audiogram bernada tulen (PTA).
Terdapat 36 pesakit yang didiagnosis dengan ISSNHL terlibat
dalam kajian ini. Selepas dua minggu SCT, lapan belas (56.3%) pesakit
mempunyai peningkatan pendengaran melebihi 10 dB. Empat belas
(43.7%) pesakit lain tidak mempunyai sebarang kemajuan pendengaran
(kurang daripada 10 dB). Berikutan itu, dua belas pesakit telah
diambil bekerja untuk mingguan IT
metilprednisolon selama tiga minggu. Pada bulan
pertama susulan selepas selesai terapi IT,
enam pesakit (50%) menunjukkan lebih daripada 10 dB peningkatan
dalam PTA
dengan min 19.37 dB (p<0.05). Daripada enam, dua pesakit mempunyai lebih daripada
20 dB penambahbaikan pendengaran. Hampir semua pesakit dalam kajian
ini menunjukkan penambahbaikan dalam mereka gejala tinitus dan
vertigo mereka. Dos tinggi IT
metilprednisolon selepas kegagalan SCT telah mengakibatkan peningkatan yang
ketara dalam keputusan pendengaran pesakit sepanjang sebulan susulan.
Terapi IT bukan sahaja memperbaiki pendengaran pesakit tetapi mengurangkan
gejala tinitus dan vertigo. Kata kunci: Intratimpanum; metilprednisolon; kehilangan pendengaran
mengejut RUJUKAN Abdullah,
A., Hazim, M.Y., Almyzan, A., Jamilah, A.G., Roslin, S., Ann,
M.T., Borhan, L., Sani, A., Lokman, S. & Boo, N.Y. 2006. Newborn
haring screening: Experience in a Malaysia hospital. Singapore
Medical Journal 47(1): 60-64. Alexander,
T.H., Harris, J.P., Nguyen, Q.T. & Vorasubin, N. 2015. Dose
effect of intratympanic dexamethasone for idiopathic sudden sensorineural
hearing loss: 24 mg/mlL is superior to 10 mg/mL. Otology &
Neurotology 36: 1321-1327. Arastou,
S., Tajedini, A. & Borghei, P. 2013. Combined intratympanic
and systemic steroid therapy for poor-prognosis sudden sensorineural
hearing loss. Iranian Journal of Otorhinolaryngology 1(25):
23-28. Arslan,
N., Oğuz, H., Demirci, M., Şafak, M.A., İslam,
A., Kaytez, S.K. & Samim, E. 2011. Combined intratympanic
and systemic use of steroids for idiopathic sudden sensorineural
hearing loss. Otology & Neurotology 32: 393-397. Battaglia,
A., Burchette, R. & Cueva, R. 2008. Combination therapy (intratympanic
dexamethasone + high-dose prednisolone taper) for the treatment
of idiopathic sudden sensorineural hearing loss. Otology &
Neurotology 28: 453-460. Bennet,
M., Kertesz, T. & Yeung, P. 2005. Hyperbaric oxygen therapy
for idiopathic sudden sensorineural hearing loss and tinnitus:
A systematic review of randomized controlled trials. Journal
of Laryngology & Otology 119: 791-798. Chandrasekhar,
S.S. 2003. Updates on methods to treat sudden hearing loss. Operative
Techniques in Otolaryngology-Head and Neck Surgery 14: 288-292.
Chau,
J.K., Lin, J.R., Atashband, S., Irvine, R.A. & Westerberg,
B.D. 2010. Systematic review of the evidence for the etiology
of adult sudden sensorineural hearing loss. Laryngoscope 120:
1011-1021. Choi,
S.J., Lee, J.B., Lim, H.J., In, S.M., Kim, J.Y., Bae, K.H. &
Choung, Y.H. 2013. Intratympanic dexamethasone injection for refractory
tinnitus: Prospective placebo-controlled study. Laryngoscope
123: 2817-2822. Cinamon,
U., Bendet, E. & Kronenberg, J. 2001. Steroids, carbogen or
placebo for sudden hearing loss: A prospective double-blind study.
European Archives of Otorhinolaryngology 258: 477-480.
Deenadayal,
D.S., Vidyasagar, D., Bommakanti, V., Goel, K. & Naeem, N.
2016a. Role of intratympanic steroids in the management of Meniere’s
disease-A review of 151 cases. International Journal of Otolaryngology
and Head & Neck Surgery 5: 108-113. Deenadayal,
D.S., Vidyasagar, D., Vyshanavi, B., Madisetty, N.K., Nakirikanti,
R.K. & Ramesh, C. 2016b. Role of intratympanic steroids in
the management of idiopathic sudden sensori neural hearing loss
- our experience of 67 cases. International Journal of Otolaryngology
and Head & Neck Surgery 5: 174-180. Ferri,
E., Frisina, A., Fasson, A.C., Armato, E., Spinato, G. & Amadori,
M. 2012. Intratympanic steroid treatment for idiopathic sudden
sensorineural hearing loss after failure of intravenous therapy.
ISRN Otolaryngology 2012: 647271. Gundogan,
O., Pinar, E., Imre, A., Ozturkcan, S., Cokmez, O. & Yigiter,
A.C. 2013. Therapeutic efficacy of the combination of intratympanic
methylprednisolone and oral steroid for idiopathic sudden deafness.
Otolaryngology Head & Neck Surgery 149: 753-758. Ho,
H.G., Lin, H.C., Shu, M.T., Yang, C.C. & Tsai, H.T. 2004.
Effectiveness of intratympanic dexamethasone injection in sudden-deafness
patients as salvage treatment. Laryngoscope 114: 1184-1189.
Hyun,
J.S. 2016. Intratympanic steroid injection in tinnitus management.
Hanyang Medical Review 36: 125-130. Jong,
D.L., Moo, K.P., Chi, K.L., Kye, H.P. & Byung, D.L. 2010.
Intratympanic steroids in severe to profound sudden sensorineural
hearing loss as salvage treatment. Clinical and Experimental
Otorhinolaryngology 3: 122-125. Kong,
M.H., Goh, B.S., Hamidah, A. & Zarina, A. 2014. The prevelance
of sensorineural hearing loss in B-thalassemia patient treated
with Desferrioxime. Medical Journal Malaysia 69(1): 9-12.
Kuhn,
M., Heman-Ackah, S.E., Shaikh, J.A. & Roehm, P.C. 2011. Sudden
sensorineural hearing loss: A review of diagnosis, treatment,
and prognosis. Trends in Amplification 15: 91-105. Mazita,
A., Abdullah, A., Awang, M.A., Liyab, B. & Lokman, S. 2008.
Relation of distortion product optoacoustic emission with tinnitus.
Laryngocope 118(4): 712-717. Moon,
I.S., Lee, J.D., Kim, J., Hong, S.J. & Lee, W.S. 2011. Intratympanic
dexamethasone is an effective method as a salvage treatment in
refractory sudden hearing loss. Otology & Neurotology 32:
1432-1436. Mühlmeier,
G., Baguley, D., Cox, T., Suckfüll, M. & Meyer, T. 2016. Characteristics
and spontaneous recovery of tinnitus related to idiopathic sudden
sensorineural hearing loss. Otology & Neurotology 37:
634-641. Noell,
C. & Meyerhoff, W. 2003. Tinnitus. Diagnosis and treatment
of this elusive symptom. Geriatrics 58: 28-34. Parnes,
L.S., Sun, A.H. & Freeman, D.J. 1999. Corticosteroid pharmacokinetics
in the inner ear fluids: An animal study followed by clinical
application. Laryngoscope 109: 1-17. Rausch, S.D., Halpin,
C.F., Antonelli, P.J., Babu, S., Carey, J.P., Gantz, B.J., Goebel,
J.A., Hammerschlag, P.E., Harris, J.P., Isaacson, B., Lee, D.,
Linstrom, C.J., Parnes, L.S., Shi, H., Slattery, W.H., Telian,
S.A., Vrabec, J.T. & Reda, D.J. 2011. Oral vs intratympanic
corticosteroid therapy for idiopathic sudden sensorineural hearing
loss: A randomized trial. Journal of the American Medical Association
305: 2071-2079. Raymundo, I.T., Bahmad, F.J., Barros
Filho, J., Piaheiro Pinheiro, T.G. & Oliveira, C.A. 2010.
Intratympanic methylprednisolone as rescue therapy in sudden sensorineural
hearing loss. Brazilian Journal of Otorhinolaryngology 76(4):
499-509. Ruszymah, B., Farah, W., Zakinah,
Y., Zahari, Z., Norazlinda, Lokman, S. & Aminuddin, B.S. 2005.
Congenital deafness: High prevalence of a V371 mutation in the
GJB2 gene among deaf school children in Alor Setar. Medical
Journal Malaysia 60(3): 269-271. She, W., Dai, Y., Du, X., Chen,
F., Ding, X. & Cui, X. 2009. Treatment of subjective tinnitus:
A comparative clinical study of intratympanic steroid injection
vs. oral carbamazepine. Medical Science Monitor 15: 135-139.
Spear, S.A. & Schwartz, S.R.
2011. Intratympanic steroids for sudden sensorineural hearing
loss: A systematic review. Otolaryngology Head and Neck Surgery
145: 534-543. Trowbridge, B.C. 1949. Tympanosympathetic
anesthesia for tinnitus aurium and secondary otalgia. Archives
of Otolaryngology 50: 200-215. Tucci, D.L., Farmer, J.C., Kitch,
R.D. & Witsell, D.L. 2002. Treatment of sudden sensorineural
hearing loss with systemic steroids and valacyclovir. Otology
& Neurotology 23: 301- 308. Wan, S.I., Fei, Z., Deepak, R. &
Mohammed, A. 2013. Measurement of subtle auditory deficit in tinnitus
patients with normal audiometric thresholds using evoked optoacoustic
emissions and threshold equalizing noise test. International
Tinnitus Journal 18(1): 35-44. Wang, M., Han, Y., Fan, Z., Zhang,
D. & Wang, H. 2016. Therapeutic effect on idiopathic sudden
sensorineural hearing loss with duration of onset more than 3
months. Indian Journal of Otolaryngology and Head & Neck
Surgery 65: 61-65. *Pengarang untuk surat-menyurat;
email: aminuddin_saim@yahoo.com
|
|||
|
